ULCOCID ULCOCID ULCOCID ULCERATE ULCERATE ULCERATE ULSANIC ULSANIC ULSANIC ULSANIC CIDIFEN CIDIFEN CIDIFEN MACRALFATE SUCRAFATE SUCRAFATE SUCRAFATE MEDGEL MEDGEL ALUSULIN ULFATE CRAFILM CRAFILM CRAFILM CHEWABLE SUCRAL SUCFATE SUCFATE SUCFATE ULCERNIL ULCERNIL ULCAFATE ULCAFATE ULCAFATE ULCERCURE FORTE ORAFATE ULCOAT SUCMED SUCMED SULCRATE SUCRALGEM MALLAR MALLAR SUCRALIX SUCRAL-HEIM ULCERCURE RALFATE RALFATE SUCRALAN ULCERTEC RAFATE RAFATE SUCRANIC EPIGARD EPIGARD MACSUFATE SUCRAGRAY DYFATE PRO-FIT ULSUC WINSANIC BIOFATE BIOFATE SUCLIVE SUCRAZ ULCELEY CRAFATE SUCROSUN CAYFATE MARIFATE SUCRALIF SUCRALIF SUCRALIF SURLKA CYTOZOLE CYTOZOLE CYTOZOLE MASFATE

Dose: 1 g
Single Dose: 1 (1)
Frequency: 6 hourly
Route: PO
Instructions:

Dose: Safety not established
Single Dose:
Frequency:
Route:
Instructions:

. It is of Synthetic origin and belongs to Glucofructose. It belongs to Antacids and Ulcer Healing pharmacological group.

Sucralfate

The symptomatic adverse reactions produced by Sucralfate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Constipation.

Sucralfate is primarily indicated in conditions like Benign gastric and duodenal ulceration and chronic gastritis, Duodenal ulcer, Peptic ulcer, Prophylaxis of stress ulceration, Reflux oesophagitis, and can also be given in adjunctive therapy as an alternative drug of choice in Benign gastric and duodenal ulceration, Inflammatory bowel disease.

Sucralfate is known to interact with other drugs, the details of drug interactions is as follows:DrugDetailsSeverityOnsetManagementCimetidine (HCl)Cimetidine (HCl)CiprofloxacinClodronateDiclofenac (K)Diclofenac (Na)DigoxinFosphenytoinKetoconazoleLansoprazoleMoxifloxacinSucralfate releases aluminium ions in the stomach and thereby reduces the absorption of moxifloxacin.Nalidixic AcidOfloxacinOxolinic AcidSucralfate reduce(s) absorption of Oxolinic acidPhenytoin (Na)QuinidineRanitidineSulpirideTetracycline (HCl)TheophyllineThyroxine (Na)Thyroxine (Na)Warfarin (Na) These interactions are sometimes beneficial and sometimes may pose threats to life. Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Drug should not be given to Paediatrics, Pregnant Mothers, patients suffering from Kidney dysfunction, and Neonates.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Susp Store at room temperature. Freezing is recommended. Tab Store in a well closed container, at room temperature.

Do not take antacids 30min before and after sucralfate. Avoid use in patients with renal impairment. It should be used in pregnancy if clearly needed.